Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Edition
European
US
Rheumatology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
The first and only approved dual inhibitor of IL-17A and IL-17F1-6
February 2026
BIMZELX® Demonstrated Deep and Sustained Efficacy to 3 Years Across Multiple Disease Domains of PsA and the Full axSpA Spectrum…
Read more
14
Mins
15 Jul 2021
Treat to Target in Spondyloarthritis: Myth or Reality?
A treat-to-target (T2T) strategy is a treatment plan in which the clinician treats the patient aggressively enough to reach and maintain explicitly specified and sequentially measured goals, such as remission, low disease activity, or absence of disability.
12
Mins
15 Jul 2021
A Worthwhile Measurement of Early Vigilance and Therapeutic Monitor in Axial Spondyloarthritis:
To examine clinical application of QSS, the authors developed a search strategy of QSS using a literature review through database of MEDLINE, Embase (Ovid), CINAHL (EBSCOhost), HaPI (Ovid), Cochrane Review (Ovid), and citation mining.
11
Mins
15 Jul 2021
The Interplay of Genes with the Gut Microbiota in the Aetiopathogenesis of Spondyloarthropathies
The spondyloarthropathies (SpA) are a spectrum of inter-related conditions that include axial spondyloarthritis (AxSpA), (also known as ankylosing spondylitis; AS), non-radiographic axial spondyloarthritis, peripheral spondyloathritis (pSpA), reactive arthritis (ReA), and enteropathic arthritis associated with Crohn’s disease (CD).
9
Mins
17 Jun 2021
Prevalence of Scoliosis in Hypermobile Ehlers-Danlos Syndrome
The main purpose of this study was to evaluate the prevalence, form, and severity of scoliosis in a population of adults meeting the 2017 criteria for hypermobile Ehlers-Danlos syndrome (hEDS).
24 May 2021
Webinar: Diclofenac in a New and Innovative Form: Low Dosages and Small Volume
In this webinar Dr. Jonathan Sackier is joined by Dr. Alia Darweish Medniuk and Dr. Juraj Kacian as they discuss the importance of the NSAID diclofenac for the management of pain in different settings/clinical situations. They will also highlight what’s new for diclofenac, namely the development of new formulations at small volume and low dosages, in line with the EMA recommendations on NSAIDs and CV risk
6
Mins
24 May 2021
Musculoskeletal Brucellosis in Adults in the United Arab Emirates: A Retrospective Study
Brucellosis is a zoonotic infection, historically known as Maltese fever, caused by aerobic Gram-negative coccobacilli, which was first identified by Sir…
6 May 2021
A Prescription of Aerobic Exercise for Rheumatic Disorders
EXERCISE reduces the risk of cardiovascular disease in those with rheumatic disorders. Individuals with autoimmune rheumatic diseases (ARDs), such as rheumatoid arthritis and lupus, are more likely to develop atherosclerosis and are thereby at a higher risk of a heart attack and other cardiovascular disorders.
6 May 2021
A Safer Strategy for Steroid Use in Patients with Lupus
LUPUS could now be treated with a lower dose of steroids, lessening the side effects experienced by patients and improving their health long-term. The research was published by Eric Morand and the Rheumatology Group at Monash University, Melbourne, Australia, who aimed to gain insight into ways of tracking patient exposure to steroids.
Loading posts...
« Previous
1
…
50
51
52
53
54
…
83
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View